Therapeutic effects of mosapride citrate and lansoprazole for prevention of aspiration pneumonia in patients receiving gastrostomy feeding

Journal of Gastroenterology

Volumn 48, Issue 10, 2013, Pages 1105-1110

  Takatori, Kento ^a   Yoshida, Rihito ^a   Horai, Aya ^a   Satake, Shinya ^a   Ose, Takayuki ^a   Kitajima, Naoto ^a   Yoneda, Shushi ^b   Adachi, Kyoichi ^c   Amano, Yuji ^d   Kinoshita, Yoshikazu ^e  

^a Kasai City Hospital   (Japan)

^b Yoneda Hospital   (Japan)

^c SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

^d International University of Health and Welfare and International University of Health and Welfare Ichikawa Hospital   (Japan)

^e SHIMANE UNIVERSITY   (Japan)

Author keywords

Aspiration pneumonia; Esophageal hiatal hernia; Lansoprazole; Mosapride citrate; Percutaneous endoscopic gastrostomy

Indexed keywords

LANSOPRAZOLE; MOSAPRIDE;

ADULT; ARTICLE; ASPIRATION PNEUMONIA; CONTROLLED STUDY; DYSPHASIA; FEEDING; FEMALE; FEVER; GASTROSTOMY; HIATUS HERNIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; VOMITING;

AGED; AGED, 80 AND OVER; ANTI-ULCER AGENTS; BENZAMIDES; DRUG THERAPY, COMBINATION; ENTERAL NUTRITION; FEMALE; GASTROSTOMY; HUMANS; INCIDENCE; LANSOPRAZOLE; MALE; MIDDLE AGED; MORPHOLINES; PNEUMONIA, ASPIRATION; PROSPECTIVE STUDIES; SEROTONIN RECEPTOR AGONISTS; TREATMENT OUTCOME;

EID: 84892808573     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-012-0725-6     Document Type: Article

References (26)

1. Grant MD, Rudberg MA, Brody JA Gastrostomy placement and mortality among hospitalized Medicare beneficiaries. JAMA. 1998; 279:1973-6.
2. Winter SM. Terminal nutrition: framing the debate for the withdrawal of nutritional support in terminally ill patients. Am J Med. 2000; 109:723-6.
3. James A, Kapur K, Hawthorne AB Long-term outcome of percutaneous endoscopic gastrostomy feeding in patients with dysphagic stroke. Age Ageing. 1998; 27:671-6.
4. Marik PE. Aspiration pneumonitis and aspiration pneumonia. N Engl J Med. 2001; 344:665-71.
5. Tokunaga T, Kubo T, Ryan S., et al Long-term outcome after placement of a percutaneous endoscopic gastrostomy tube. Geriatr Gerontol Int. 2008; 8:19-23.
6. Mine Y, Yoshikawa T, Oku S., Nagai R, Yoshida N, Hosoki K. Comparison of effect of mosapride citrate and existing 5-HT4 receptor agonists on gastrointestinal motility in vivo and in vitro. J Pharmacol Exp Ther. 1997; 283:1000-8.
7. Ruth M, Hamelin B, Rohss K., Lundell L. The effect of mosapride, a novel prokinetic, on acid reflux variables in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 1998; 12:35-40.
8. Hawkey CJ, Long RG, Bardhan K.D., et al Improved symptom relief and duodenal ulcer healing with lansoprazole, a new proton pump inhibitor, compared with ranitidine. Gut. 1993; 34:1458-62.
9. Hett DA, Scott RC, Risdall JE Lansoprazole in the prophylaxis of acid aspiration during elective surgery. Br J Anaesth. 1995; 74: 614-5.
10. Langtry HD, Wilde MI Lansoprazole. An update of its pharmacological properties and clinical efficacy in the management of acid-related disorders. Drugs. 1997; 54:473-500.
11. Mikawa K, Nishina K, Maekawa N., Asano M, Obara H. Lansoprazole reduces preoperative gastric fluid acidity and volume in children. Can J Anaesth Journal canadien d'anesthesie. 1995; 42:467-72.
12. Niederman MS, Bass JB Jr, Campbell GD, et al Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association. Am Rev Respir Dis. 1993; 148:1418-26.
13. Brody H. Evidence-based medicine, nutritional support, and terminal suffering. Am J Med. 2000; 109:740-1.
14. Peck A, Cohen CE, Mulvihill MN Long-term enteral feeding of aged demented nursing home patients. J Am Geriatr Soc. 1990; 38:1195-8.
15. Cole MJ, Smith JT, Molnar C, Shaffer EA Aspiration after percutaneous gastrostomy. Assessment by Tc-99m labeling of the enteral feed. J Clin Gastroenterol. 1987; 9:90-5.
16. Short TP, Patel NR, Thomas E. Prevalence of gastroesophageal reflux in patients who develop pneumonia following percutaneous endoscopic gastrostomy: a 24-hour pH monitoring study. Dysphagia. 1996; 11:87-9.
17. Ono H, Azuma T, Miyaji H., et al Effects of percutaneous endoscopic gastrostomy tube placement on gastric antral motility and gastric emptying. J Gastroenterol. 2003; 38:930-6.
18. He M, Ohrui T, Ebihara T., Ebihara S, Sasaki H, Arai H. Mosapride citrate prolongs survival in stroke patients with gastrostomy. J Am Geriatr Soc. 2007; 55:142-4.
19. Baldi F, Malfertheiner P. Lansoprazole fast disintegrating tablet: a new formulation for an established proton pump inhibitor. Digestion. 2003; 67:1-5.
20. Herzig SJ, Howell MD, Ngo L.H., Marcantonio ER Acid-suppressive medication use and the risk for hospital-acquired pneumonia. JAMA. 2009; 301:2120-8.
21. Johnstone J, Nerenberg K, Loeb M. Meta-analysis: proton pump inhibitor use and the risk of community-acquired pneumonia. Aliment Pharmacol Ther. 2010; 31:1165-77.
22. McCullough P, Benson D. Acid-suppressive medication and hospital-acquired pneumonia. JAMA 2009; 302:1415-6; (author reply 16-7).
23. Sarkar M, Hennessy S, Yang YX Proton-pump inhibitor use and the risk for community-acquired pneumonia. Ann Intern Med. 2008; 149:391-8.
24. Savarino V, Di Mario F, Scarpignato C. Proton pump inhibitors in GORD An overview of their pharmacology, efficacy and safety. Pharmacol Res Off J Italian Pharmacol Soc. 2009; 59: 135-53.
25. Shizuku T, Adachi K, Furuta K., et al Efficacy of half-solid nutrient for the elderly patients with percutaneous endoscopic gastrostomy. J Clin Biochem Nutr. 2011; 48:226-9.
26. Adachi K, Furuta K, Morita T., et al Half-solidification of nutrient does not decrease gastro-esophageal reflux events in patients fed via percutaneous endoscopic gastrostomy. Clin Nutr. 2009; 28:648-51.